Differential Effect of Glucose on ER-Mitochondria Ca


Journal

Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763

Informations de publication

Date de publication:
09 2019
Historique:
received: 15 10 2018
accepted: 04 06 2019
pubmed: 9 6 2019
medline: 21 3 2020
entrez: 9 6 2019
Statut: ppublish

Résumé

Glucotoxicity-induced β-cell dysfunction in type 2 diabetes is associated with alterations of mitochondria and the endoplasmic reticulum (ER). Both organelles interact at contact sites, defined as mitochondria-associated membranes (MAMs), which were recently implicated in the regulation of glucose homeostasis. The role of MAMs in β-cells is still largely unknown, and their implication in glucotoxicity-associated β-cell dysfunction remains to be defined. Here, we report that acute glucose treatment stimulated ER-mitochondria interactions and calcium (Ca

Identifiants

pubmed: 31175102
pii: db18-1112
doi: 10.2337/db18-1112
doi:

Substances chimiques

Glucose IY9XDZ35W2
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1778-1794

Informations de copyright

© 2019 by the American Diabetes Association.

Auteurs

Florian Dingreville (F)

CarMeN Laboratory, INSERM, INRA, INSA, Université Claude Bernard Lyon 1, Oullins, France.

Baptiste Panthu (B)

CarMeN Laboratory, INSERM, INRA, INSA, Université Claude Bernard Lyon 1, Oullins, France.

Charles Thivolet (C)

CarMeN Laboratory, INSERM, INRA, INSA, Université Claude Bernard Lyon 1, Oullins, France.
Department of Endocrinology and Diabetes, Hospices Civils de Lyon, Hopital Lyon Sud, Pierre-Bénite, France.

Sylvie Ducreux (S)

CarMeN Laboratory, INSERM, INRA, INSA, Université Claude Bernard Lyon 1, Oullins, France.

Yves Gouriou (Y)

CarMeN Laboratory, INSERM, INRA, INSA, Université Claude Bernard Lyon 1, Oullins, France.

Sandra Pesenti (S)

CarMeN Laboratory, INSERM, INRA, INSA, Université Claude Bernard Lyon 1, Oullins, France.

Marie-Agnès Chauvin (MA)

CarMeN Laboratory, INSERM, INRA, INSA, Université Claude Bernard Lyon 1, Oullins, France.

Karim Chikh (K)

Department of Endocrinology and Diabetes, Hospices Civils de Lyon, Hopital Lyon Sud, Pierre-Bénite, France.

Elisabeth Errazuriz-Cerda (E)

CIQLE, Université Claude Bernard Lyon 1, Lyon, France.

Fabien Van Coppenolle (F)

CarMeN Laboratory, INSERM, INRA, INSA, Université Claude Bernard Lyon 1, Oullins, France.

Jennifer Rieusset (J)

CarMeN Laboratory, INSERM, INRA, INSA, Université Claude Bernard Lyon 1, Oullins, France anne-marie.coquelet-madec@univ-lyon1.fr jennifer.rieusset@univ-lyon1.fr.

Anne-Marie Madec (AM)

CarMeN Laboratory, INSERM, INRA, INSA, Université Claude Bernard Lyon 1, Oullins, France anne-marie.coquelet-madec@univ-lyon1.fr jennifer.rieusset@univ-lyon1.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH